| 15h ago | | Shares sink on U.S. stimulus pullback, Chinese growth fears |
| 3d ago | DJ | MARKET SNAPSHOT: U.S. Stocks Drop, Retreating From All-time Highs |
| 3d ago | | Actavis to buy Warner Chilcott in $5 billion stock deal |
| 3d ago | DJ | MARKET SNAPSHOT: U.S. Stocks Slip After Hitting All-time Highs |
| 3d ago | DJ | Actavis to Buy Warner Chilcott for $5 Billion in Stock |
| 3d ago | DJ | MARKET SNAPSHOT: U.S. Stocks Grind Higher To All-time Highs |
| 3d ago | DJ | MARKET SNAPSHOT: U.S. Stocks Grind Higher To All-time Highs |
| 3d ago | DJ | Actavis to Buy Warner Chilcott For $5 Billion in Stock |
| 3d ago | DJ | MARKET SNAPSHOT: U.S. Stocks Waver; Deal News, Fed In Focus |
| 3d ago | DJ | MARKET SNAPSHOT: U.S. Stocks Waver; Deal News, Fed In Focus |
| 3d ago | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 3d ago | | Actavis to buy Warner Chilcott in $5 billion stock deal |
| 3d ago | DJ | Actavis to Buy Warner Chilcott for $5 Billion in Stock |
| 3d ago | | ACTAVIS INC: Actavis to Acquire Warner Chilcott to Create Premier $11 Billion R.. |
| 05/15 | DJ | Novartis Considers Possible Bid for Actavis |
| 05/14 | | Actavis rejected $15 billion offer from Mylan |
| 05/14 | | ACTAVIS INC: Announcement Under Irish Takeover Rules Relevant Securities in Iss.. |
| 05/13 | | ACTAVIS INC: Actavis' NDA for Progestin-Only Patch Accepted for Filing by FDA |
| 05/13 | | ACTAVIS INC: Actavis Cancels Presentation at Bank of America Merrill Lynch Heal.. |
| 05/13 | DJ | U.S. HOT STOCKS FUTURES: Hot stocks to watch |
| 05/10 | | ACTAVIS INC: Actavis Confirms Early Stage Discussions Regarding Potential Combi.. |
| 05/10 | DJ | Actavis in Early Talks About Buyout of Warner Chilcott |
| 05/09 | | ACTAVIS INC: Actavis Confirms District Court Ruling In Generic Lialda® Patent S.. |
| 05/09 | DJ | Shire Prevails in Litigation over LIALDA Colitis Treatment |
| 05/07 | | ACTAVIS INC: Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013.. |
| 05/07 | DJ | Endo Health Swings to First-Quarter Profit On Strong Generic Drug Sales |
| 05/03 | | ACTAVIS INC: Actavis to Host Annual Meeting of Stockholders on May 10, 2013 |
| 05/02 | DJ | Valeant Posts 1st-Quarter Loss; Adjusted Earnings Beat |
| 05/02 | | Valeant adjusted profit up; raises profit forecast |
| 05/02 | DJ | Actavis Swings to 1st-Quarter Loss on Charges; Raises Year View |
| 05/02 | | ACTAVIS INC: Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billi.. |
| 05/01 | | Actavis buys antibiotic vaginal gel from Valeant for $55 million |
| 05/01 | | ACTAVIS INC: Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3%.. |
| 04/30 | | Deal maker Valeant reaches for biggest prize yet |
| 04/29 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 04/27 | | Merger of drugmakers Valeant, Actavis on hold |
| 04/27 | | Merger of drugmakers Valeant, Actavis on hold |
| 04/26 | | VALEANT IN TALKS TO BUY ACTAVIS FOR : Wsj |
| 04/26 | | ACTAVIS INC: Actavis Announces OxyContin® Patent Challenge Settlement |
| 04/25 | | ACTAVIS INC: Actavis Reaches Agreement with Shire to Launch a Generic Version o.. |
| 04/16 | | ACTAVIS INC: Actavis Confirms Favorable Ruling in Generic Yaz® Patent Suit |
| 04/10 | | ACTAVIS INC: Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call .. |
| 04/10 | | ACTAVIS INC: Actavis Reaches Agreements with Valeant to Launch Generic Versions.. |
| 04/05 | | ACTAVIS INC: Actavis and Valeant Announce Actavis as Exclusive Authorized Gener.. |
| 04/03 | DJ | Actavis Temporarily Enjoined From Selling Generic of AstraZeneca's Pulmicort .. |
| 04/03 | | AstraZeneca wins temporary block on Actavis asthma drug |
| 04/03 | | ACTAVIS INC: Actavis Confirms Court Issues TRO Related to Generic Pulmicort RES.. |
| 04/02 | | AstraZeneca suffers fresh drug patent setback in U.S. |
| 04/02 | DJ | Court Rules AstraZeneca's U.S. Pulmicort Patent Invalid |
| 04/02 | DJ | Court Rules AstraZeneca's U.S. Pulmicort Patent Invalid |
| 04/01 | | ACTAVIS INC: Actavis Confirms Favorable Ruling In Generic Pulmicort RESPULES® P.. |
| 04/01 | | ACTAVIS INC: Actavis Confirms Generic AndroGel® 1.62% Patent Challenge |
| 03/25 | DJ | Supreme Court Concerned About Drug Patent Settlements |
| 03/25 | DJ | Supreme Court Voices Concerns on Drug Patent Settlements |
| 03/25 | | AstraZeneca settles Crestor patent row |
| 03/25 | DJ | AstraZeneca Settles Suit, Protecting Crestor |
| 03/25 | DJ | AstraZeneca Settles Litigation Over Crestor Patent |
| 03/25 | | ACTAVIS INC: Actavis Reaches Agreement with AstraZeneca to Launch a Generic Ver.. |
| 03/08 | | ACTAVIS INC: Actavis Confirms Generic Exelon® Patch Patent Challenge |
| 03/06 | | ACTAVIS INC: Actavis launches Montelukast as patents expire in Europe |
| 03/05 | DJ | Pfizer Gets Reissued Celebrex Patent, Extends Exclusivity |
| 03/05 | DJ | Pfizer Get Reissued Patent for Celebrex |
| 03/05 | DJ | Pfizer Get Reissued Patent for Celebrex; Extends Exclusivity to 2015 |
| 03/05 | | ACTAVIS INC: Teva Pharma, Zoetis, Orexigen Therapeutics, Novartis, and Actavis .. |
| 03/01 | | ACTAVIS INC: Actavis Confirms Generic Fortesta® Patent Challenge |
| 02/14 |  | ACTAVIS INC: quaterly earnings release |
| 02/06 | DJ | Concerns Rise Ahead of Amgen's Business Update Thursday |
| 02/01 | | ACTAVIS INC: Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call.. |
| 01/31 | DJ | Pfizer Wins Rapamune Patent Suit Against Actavis |
| 01/31 | | ACTAVIS INC: Actavis Confirms District Court Ruling In Generic Rapamune® Patent.. |
| 01/31 | DJ | Pfizer Wins Rapamune Patent Suit Against Actavis |
| 01/24 | | WATSON PHARMACEUTICALS, INC.: is Now Actavis, Inc. |
| 01/23 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Opana® ER Patent Challenge |
| 01/23 | | WATSON PHARMACEUTICALS, INC.: Watson Acquires Uteron Pharma SA |
| 01/11 | | WATSON PHARMACEUTICALS, INC.: Watson To Host 2013 Investor Meeting January 25 I.. |
